+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Virus Filtration Market 2020-2026 by Product (Consumables, Instruments, Services), Application, End User, and Country: COVID-19 Impact and Growth Opportunity

  • ID: 5206692
  • Report
  • November 2020
  • Region: Asia Pacific
  • 103 pages
  • GMD Research

Order now to receive an updated version of this report covering the impact of COVID-19.

Enquire Now

FEATURED COMPANIES

  • Clean Cells
  • General Electric Company
  • Lonza Group AG
  • Merck KGaA
  • MilliporeSigma
  • Pall Corporation
Asia Pacific virus filtration market will grow by 14.72% annually with a total addressable market cap of $8,116.1 million over 2020-2026 owing to the rapid growth of pharmaceutical and biotechnology industry, increasing investments in R&D, surging need for virus removal and clearance amid COVID-19 pandemic.

Highlighted with 32 tables and 45 figures, this 103-page report “Asia Pacific Virus Filtration Market 2020-2026 by Product (Consumables, Instruments, Services), Application, End User, and Country: COVID-19 Impact and Growth Opportunity” is based on a holistic research of the entire Asia Pacific virus filtration market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides forecast from 2020 till 2026 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific virus filtration market in every aspect of the classification from perspectives of Product, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.

Consumables

Instruments
  • Filtration Systems
  • Chromatography systems
Services

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.

Biological Applications
  • Vaccines and Therapeutics
  • Blood and Blood Products
  • Cellular and Gene Therapy Products
  • Tissue and Tissue Products
  • Stem Cell Products
Medical Devices

Water Purification

Air Purification

Other Applications

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organisations (CROs)
  • Academic & Research Institutes
  • Medical Device Companies
  • Other End Users
Geographically, the following national/local markets are fully investigated:
  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2016-2026. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Asia Pacific virus filtration market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • Asahi Kasei Medical Co., Ltd.
  • Charles River Laboratories International, Inc.
  • Clean Cells
  • General Electric Company
  • Lonza Group AG
  • Merck KGaA
  • MilliporeSigma
  • Pall Corporation
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
  • Wuxi Apptec
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Clean Cells
  • General Electric Company
  • Lonza Group AG
  • Merck KGaA
  • MilliporeSigma
  • Pall Corporation
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Asia Pacific Market by Product
3.1 Market Overview by Product
3.2 Consumables
3.3 Instruments
3.3.1 Filtration Systems
3.3.2 Chromatography systems
3.4 Services

4 Segmentation of Asia Pacific Market by Application
4.1 Market Overview by Application
4.2 Biological Applications
4.2.1 Vaccines and Therapeutics
4.2.2 Blood and Blood Products
4.2.3 Cellular and Gene Therapy Products
4.2.4 Tissue and Tissue Products
4.2.5 Stem Cell Products
4.3 Medical Devices
4.4 Water Purification
4.5 Air Purification
4.6 Other Applications

5 Segmentation of Asia Pacific Market by End User
5.1 Market Overview by End User
5.2 Pharmaceutical and Biotechnology Companies
5.3 Contract Research Organisations (CROs)
5.4 Academic & Research Institutes
5.5 Medical Device Companies
5.6 Other End Users

6 Asia-Pacific Market 2019-2026 by Country
6.1 Overview of Asia-Pacific Market
6.2 China
6.3 Japan
6.4 India
6.5 Australia
6.6 South Korea
6.7 Rest of APAC Region

7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
  • Asahi Kasei Medical Co., Ltd.
  • Charles River Laboratories International, Inc.
  • Clean Cells
  • General Electric Company
  • Lonza Group AG
  • Merck KGaA
  • MilliporeSigma
  • Pall Corporation
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
  • Wuxi Apptec
8 Investing in Asia Pacific Market: Risk Assessment and Management
8.1 Risk Evaluation of Asia Pacific Market
8.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of Asia Pacific Virus Filtration Market in Balanced Perspective, 2019-2026
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Virus Filtration Market
Table 4. Asia Pacific Virus Filtration Market by Product, 2016-2026, $ mn
Table 5. Asia Pacific Virus Filtration Market: Instruments by Technology, 2016-2026, $ mn
Table 6. Asia Pacific Virus Filtration Market by Application, 2016-2026, $ mn
Table 7. Asia Pacific Virus Filtration Market: Biological Applications by Segment, 2016-2026, $ mn
Table 8. Asia Pacific Virus Filtration Market by End User, 2016-2026, $ mn
Table 9. APAC Virus Filtration Market by Country, 2016-2026, $ mn
Table 10. China Virus Filtration Market by Product, 2016-2026, $ mn
Table 11. China Virus Filtration Market by Application, 2016-2026, $ mn
Table 12. China Virus Filtration Market by End User, 2016-2026, $ mn
Table 13. Japan Virus Filtration Market by Product, 2016-2026, $ mn
Table 14. Japan Virus Filtration Market by Application, 2016-2026, $ mn
Table 15. Japan Virus Filtration Market by End User, 2016-2026, $ mn
Table 16. India Virus Filtration Market by Product, 2016-2026, $ mn
Table 17. India Virus Filtration Market by Application, 2016-2026, $ mn
Table 18. India Virus Filtration Market by End User, 2016-2026, $ mn
Table 19. Australia Virus Filtration Market by Product, 2016-2026, $ mn
Table 20. Australia Virus Filtration Market by Application, 2016-2026, $ mn
Table 21. Australia Virus Filtration Market by End User, 2016-2026, $ mn
Table 22. South Korea Virus Filtration Market by Product, 2016-2026, $ mn
Table 23. South Korea Virus Filtration Market by Application, 2016-2026, $ mn
Table 24. South Korea Virus Filtration Market by End User, 2016-2026, $ mn
Table 25. Virus Filtration Market in Rest of APAC by Country, 2016-2026, $ mn
Table 26. Asahi Kasei Medical Co., Ltd.: Company Snapshot
Table 27. Asahi Kasei Medical Co., Ltd.: Business Segmentation
Table 28. Asahi Kasei Medical Co., Ltd.: Product Portfolio
Table 29. Asahi Kasei Medical Co., Ltd.: Revenue, 2016-2018, $ mn
Table 30. Asahi Kasei Medical Co., Ltd.: Recent Developments
Table 31. Risk Evaluation for Investing in Asia Pacific Market, 2019-2026
Table 32. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026
Figure 5. Asia Pacific Virus Filtration Market, 2019-2026, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Virus Filtration Market
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Virus Filtration Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Five Forces Analysis of Asia Pacific Virus Filtration Market
Figure 11. Breakdown of Asia Pacific Virus Filtration Market by Product, 2019-2026, % of Revenue
Figure 12. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Product, Value ($ mn) and Share (%)
Figure 13. Asia Pacific Virus Filtration Market: Consumables, 2016-2026, $ mn
Figure 14. Asia Pacific Virus Filtration Market: Instruments, 2016-2026, $ mn
Figure 15. Asia Pacific Virus Filtration Market: Filtration Systems, 2016-2026, $ mn
Figure 16. Asia Pacific Virus Filtration Market: Chromatography systems, 2016-2026, $ mn
Figure 17. Asia Pacific Virus Filtration Market: Services, 2016-2026, $ mn
Figure 18. Breakdown of Asia Pacific Virus Filtration Market by Application, 2019-2026, % of Revenue
Figure 19. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%)
Figure 20. Asia Pacific Virus Filtration Market: Biological Applications, 2016-2026, $ mn
Figure 21. Asia Pacific Virus Filtration Market: Vaccines and Therapeutics, 2016-2026, $ mn
Figure 22. Asia Pacific Virus Filtration Market: Blood and Blood Products, 2016-2026, $ mn
Figure 23. Asia Pacific Virus Filtration Market: Cellular and Gene Therapy Products, 2016-2026, $ mn
Figure 24. Asia Pacific Virus Filtration Market: Tissue and Tissue Products, 2016-2026, $ mn
Figure 25. Asia Pacific Virus Filtration Market: Stem Cell Products, 2016-2026, $ mn
Figure 26. Asia Pacific Virus Filtration Market: Medical Devices, 2016-2026, $ mn
Figure 27. Asia Pacific Virus Filtration Market: Water Purification, 2016-2026, $ mn
Figure 28. Asia Pacific Virus Filtration Market: Air Purification, 2016-2026, $ mn
Figure 29. Asia Pacific Virus Filtration Market: Other Applications, 2016-2026, $ mn
Figure 30. Breakdown of Asia Pacific Virus Filtration Market by End User, 2019-2026, % of Revenue
Figure 31. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%)
Figure 32. Asia Pacific Virus Filtration Market: Pharmaceutical and Biotechnology Companies, 2016-2026, $ mn
Figure 33. Asia Pacific Virus Filtration Market: Contract Research Organisations (CROs), 2016-2026, $ mn
Figure 34. Asia Pacific Virus Filtration Market: Academic & Research Institutes, 2016-2026, $ mn
Figure 35. Asia Pacific Virus Filtration Market: Medical Device Companies, 2016-2026, $ mn
Figure 36. Asia Pacific Virus Filtration Market: Other End Users, 2016-2026, $ mn
Figure 37. Breakdown of APAC Virus Filtration Market by Country, 2019 and 2026, % of Revenue
Figure 38. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 39. Virus Filtration Market in China, 2016-2026, $ mn
Figure 40. Virus Filtration Market in Japan, 2016-2026, $ mn
Figure 41. Virus Filtration Market in India, 2016-2026, $ mn
Figure 42. Virus Filtration Market in Australia, 2016-2026, $ mn
Figure 43. Virus Filtration Market in South Korea, 2016-2026, $ mn
Figure 44. Virus Filtration Market in Rest of APAC, 2016-2026, $ mn
Figure 45. Growth Stage of Asia Pacific Virus Filtration Industry over the Forecast Period
Note: Product cover images may vary from those shown
  • Asahi Kasei Medical Co., Ltd.
  • Charles River Laboratories International, Inc.
  • Clean Cells
  • General Electric Company
  • Lonza Group AG
  • Merck KGaA
  • MilliporeSigma
  • Pall Corporation
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
  • Wuxi Apptec
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll